Physician profile
Christopher Jetter
NPI 1457615064
$10,018.44
in general payments reported to CMS, 2019-2025
25 companies · $1,617 in 2025
The $1,617 reported for 2025 was more than what 87% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $192 · 2020: $2,201 · 2021: $1,866 · 2022: $2,780 · 2023: $1,210 · 2024: $152 · 2025: $1,617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,588 · Food and Beverage: $1,318 · Education: $72.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,588.36 |
| Food and Beverage | $1,318.18 |
| Education | $72.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,151.46 | 2021-2025 | Ortholoc 2 Lapifuse, Prostep, Axsos |
| Wright Medical Technology, INC. | $2,154.59 | 2019-2020 | |
| Paragon 28, INC. | $1,608.07 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $798.34 | 2021-2024 | Incore Lapidus, Affixus, Ceramentbone Void Filler |
| Smith+Nephew, INC. | $368.00 | 2019-2024 | Collagenase Santyl, Stravix, Grafix Pl |
| Organogenesis INC. | $196.13 | 2021-2024 | Puraply |
| Grt US Holding, INC. | $97.87 | 2021-2022 | |
| Bioventus LLC | $97.47 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $96.92 | 2021-2022 | |
| Linvatec Corporation | $74.72 | 2023 | Biobrace 23mm |
| Bone Support INC. | $51.23 | 2025 | Ceramentbone Void Filler, Cerament G |
| Treace Medical Concepts, INC. | $49.61 | 2022 | |
| Alaska Medical Technologies, LLC | $40.00 | 2025 | |
| Horizon Therapeutics Plc | $27.98 | 2019 | |
| Innovation Technologies INC | $26.70 | 2025 | Irrisept |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $25.82 | 2023 | Senza |
| Amgen INC. | $23.00 | 2024 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $20.96 | 2024 | Exparel |
| Averitas Pharma INC. | $19.44 | 2023 | Qutenza |
| Next Science LLC | $17.90 | 2021 | |
| Tactile Systems Technology INC | $16.11 | 2023 | Flexitouch Plus, Entre Plus |
| Abbott Laboratories | $15.60 | 2023 | Proclaim |
| Medtronic, INC. | $14.95 | 2023 | Accurian |
| Inari Medical, INC. | $14.52 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Jetter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.